Skip to main content
Equibles

ENVESTNET ASSET MANAGEMENT INC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1407543 Berwyn, PA
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$12,754,231
+$5,851,133 QoQ
Shares Held
40,350
+16.7% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#76
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ENVESTNET ASSET MANAGEMENT INC holds $901,256,539 across 108 Biotechnology names. LGND ranks #15 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 487,627 $242,218,959
2 REGN
Regeneron Pharmaceuticals, Inc.
 109,838 $68,488,386
3 EXEL
Exelixis, Inc.
 949,669 $51,671,490
4 ARGX
Argenx SE
 55,346 $51,348,358
5 ALNY
Alnylam Pharmaceuticals, Inc.
 136,395 $41,058,986
6 INSM
INSMED Inc
 336,997 $35,930,620
7 RPRX
Royalty Pharma plc
 513,096 $28,769,292
8 ROIV
Roivant Sciences Ltd.
 713,946 $25,266,548

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,754,231 40,350
2026-03-31 $6,903,098 34,576
2025-12-31 $5,243,856 27,735
2025-09-30 $5,653,423 31,915
2025-06-30 $3,112,217 27,377
2025-03-31 $2,797,565 26,608
2024-12-31 $9,342,944 87,195
2024-09-30 $8,636,265 86,285
2024-06-30 $6,708,107 79,612
2024-03-31 $3,939,724 53,895
2023-12-31 $3,222,470 45,120
2023-09-30 $2,623,776 43,788
2023-06-30 $2,730,571 37,872
2023-03-31 $5,318,020 72,295
2022-12-31 $2,038,134 30,511
2022-09-30 $2,599,573 30,189
2022-06-30 $2,374,856 26,618
2022-03-31 $2,646,665 23,528
2021-12-31 $3,333,709 21,583
2021-09-30 $2,250,434 16,153
2021-06-30 $1,983,330 15,118
2021-03-31 $1,550,111 10,168
2020-12-31 $1,340,187 13,476
2020-09-30 $2,200,271 23,083
2020-06-30 $2,274,804 20,338
2020-03-31 $1,468,142 20,189